Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Genentech offers HEMLIBRA update
Genentech.
New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®
RIDGEFIELD, Conn.
Bluebird, Celgene to share U.S. costs, profits on lead cancer CAR-T
Bluebird bio has pulled the trigger on an option to co-develop and co-promote the anti-BCMA CAR-T treatment, bb2121, with Celgene in the U.
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
THOUSAND OAKS, Calif.
Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy study evaluating tafamidis for the treatment of transthyretin cardiomyopathy met its primary endpoint
Pfizer Inc.
Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab
Zug, Switzerland – March 29, 2018 – Shire plc (LSE.
Israel aims for 100,000 people to volunteer for health database
TEL AVIV (Reuters) - Israel plans to collect data over five years for its digital health project and hopes 100,000 people will volunteer to include their medical records in a database it estim...
Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis
NEWARK, Calif.
Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel
Roche (SIX.
Drug compound shows promise against rheumatoid arthritis
Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis.
Drugmaker Shire soars as Japan's Takeda considers bid
LONDON/TOKYO (Reuters) - Japan’s largest drugmaker Takeda Pharmaceutical (4502.
New drug significantly reduces smoking habit in heart attack patients
Patients who smoke after an acute coronary syndrome, including a heart attack (myocardial infarction) or unstable angina (reduced blood flow to the heart) are at increased risk of anot...
450
451
452
453
454
455
456
457
458
